Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | BCL9 | O00512 | 1/20 | 0.47 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | CRHBP | P24387 | 1/20 | 0.45 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6600772 | 0.92 | HTR2A (0.61) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL125510 | 0.89 | HTR2A (0.56) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL10062010 | 0.89 | HTR2A (0.56) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL9846616 | 0.87 | HTR2A (0.58) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL23044637 | 0.85 | HTR2A (0.53) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL12082016 | 0.85 | HTR2A (0.53) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL30232973 | 0.85 | BCL9 (0.57) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL1104745 | 0.85 | HTR2A (0.53) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL30233044 | 0.85 | HTR2A (0.53) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL40213 | 0.85 | HTR2A (0.53) | HTR2ABCL9CTNNB1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130149783-A1 | CLEAVABLE MODIFICATIONS TO REDUCIBLE POLY (AMIDO ETHYLENIMINES)S TO ENHANCE NUCLEOTIDE DELIVERY | YOCKMAN JAMES WILLIAM (US) | 2013-06-13 | — | — | US | disclosed |